Silo Pharma, Inc.
SILO
$0.7261
-$0.053-6.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.40% | -86.33% | 0.32% | -16.23% | 28.50% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -100.00% | 750.00% | -100.30% |
| Change in Net Operating Assets | -175.18% | 292.51% | -311.78% | 647.38% | -125.17% |
| Cash from Operations | -78.80% | 31.87% | -84.00% | 12.69% | 7.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,411.41% | 6.68% | -104.23% | 877.77% | -97.80% |
| Cash from Investing | 2,411.41% | 6.68% | -104.23% | 877.77% | -97.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 4.08% | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | 50.04% | 40.59% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 7.79% | 1,498.79% | 40.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.50% | -369.35% | -80.71% | 314.72% | -125.75% |